To narrow down the range of potential therapeutic targets in 192 up-regulated genes identified in our HNSCC samples, we mainly focused on the genes encoding cell surface receptors and some cytoplasmic proteins. The gene discussed is CD177; the disease is head and neck squamous cell carcinoma.